News Focus
News Focus
icon url

BFTunechi

04/11/19 3:57 PM

#67785 RE: CSCS #67784

Hi CSCS I know someone posted a week or two ago a S8 about KkR issuing 125 mm shares for incentive program at .01 par value. If you do that math it’s roughly 30k off of what the KERP charge is. Is that an odd coincidence or could they have paid in stock?
icon url

trader59

04/11/19 3:59 PM

#67786 RE: CSCS #67784

Yet another misrepresentation of fact.

First off, the subject of the "mystery letter" from LCY is clearly stated, namely "A letter from LCY affirming this offer is also enclosed." ALL THAT MEANS is LCY confirmed they're participating in the joint venture that made the bid on the assets, and nothing more. There's no mystery there despite attempts to stir one up.

And, most importantly, there is not one single way for the secured creditors to receive full payment without the court authorizing it and having a direct trail to the transaction which provided the proceeds, none.

Couldn't care less how many key employees stuck around, they didn't get paid the KERP.

Either pony up evidence of full payment of all the secured debt, $40M worth, a direct statement from the court, judge, or monitor that says they've paid it all off, or give up this false narrative attempting to sell stock.
icon url

Brucebannerr

04/11/19 7:20 PM

#67807 RE: CSCS #67784

Nope pure fantasy. Here are the facts as explained to the court . You got any other transaction you can post a link to ?

The Second Sale Process led to the sale of the vast majority of the Company’s assets based on a joint
bid by Visolis Inc. and LCY Technologies Inc. (the “Visolis Transaction”). The Visolis Transaction
was an asset purchase transaction involving the vast majority of the Company’s physical assets and
intellectual property. It did not include the shares of BioAmber Inc. or any of the Company’s
subsidiaries, nor did it include the cash, accounts receivable or inventory of the Company.